HARRISON THOMAS L 4

What Happened
Thomas L. Harrison, a member of Acurx Pharmaceuticals' board of directors, received a stock option award for 2,150 shares on April 20, 2026. The Form 4 reports the grant as a derivative award at $0.00 per share (no cash exchanged reported). This is a board compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: April 20, 2026; Form 4 filed April 22, 2026 (appears filed within required two business days).
• Award: 2,150 share-equivalent stock options; price shown on the filing: $0.00 (derivative).
• Vesting: Shares subject to the options vest on April 20, 2027 (footnote: grant made under the Issuer's Director Compensation Policy).
• Shares owned after transaction: not specified in the filing.
• Filing timeliness: filed April 22 for an April 20 transaction — appears timely (not marked late).

Context
This is a standard director compensation option grant. As a derivative award, it gives Harrison the right to acquire shares in the future subject to vesting and any exercise terms; it is not an immediate purchase or sale of shares. Such grants are common for board service and do not, by themselves, indicate the director bought or sold stock for personal liquidity reasons.